Zafgen (Nasdaq:ZFGN) is a biopharmaceutical company that has leveraged its proprietary MetAP2 biology platform to pioneer the study of MetAP2 inhibitors in both common and rare metabolic disorders.
Copyright West LLC. Minimum 15 minutes delayed.
- 3 mo.
- 6 mo.
- 1 yr.